Product Details for: Tezspire
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
210MG/1.91ML (110MG/ML)
Single-Dose Vial
351(a)
Tezspire
Rx
002
Injection
Subcutaneous
210MG/1.91ML (110MG/ML)
Pre-Filled Syringe
351(a)
Tezspire
Rx
003
Injection
Subcutaneous
210MG/1.91ML (110MG/ML)
Autoinjector
351(a)
Tezspire
Rx
Proper Name
tezepelumab-ekko
tezepelumab-ekko
BLA Number
761224
761224
Applicant
AstraZeneca AB
AstraZeneca AB
Original Approval Date
December 17, 2021
December 17, 2021
Date of First Licensure